CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ivy Medical Chemicals PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ivy Medical Chemicals PLC
54 Sun Street, Waltham Abbey
Phone: 0800 0834 753p:0800 0834 753 Essex, EN9 1EJ  United Kingdom Ticker: IVMPIVMP
This company is no longer actively traded on any major stock exchange.
Business Summary
Ivy Medical Chemicals PLC is a United Kingdom-based company. The Company is engaged in development of a new treatment for cancer in animals and human patients and to undertake the necessary procedures of licensing, manufacturing and sales. Its product is CV 247 for use in dogs, which is a combination product comprising of Sodium Salicylate, Copper Gluconate, Manganese Gluconate and Ascorbic Acid (Vitamin C) taken as a solution. In Hungry, it has commissioned a trail on 40 rats to investigate the anti-oxidant effect of CV 247. The results of this trial show that the product to have such an effect. The Company’s wholly owned subsidiary is Ivy Medical Chemicals Development Limited, which is engaged in development of cancer treatments. The Company has 50% interest in Ad Astra-Ivy Medical Hungary Kft.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201012/31/2009Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Finance Director, Company Secretary, Director JohnHeywood
Managing Director, Director JosephMarffy
Scientific Director, Director RogerOakes 5/17/2010 5/17/2010

General Information
Number of Employees: 2 (As of 12/31/2009)
Outstanding Shares: 13,661,342 (As of 9/22/2010)
Stock Exchange: LON
Email Address: info@ivymedical.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023